-
Loading metrics
Open Access
Peer-reviewed
Research Article
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
-
Stephanie I. Kim,
Roles Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Affiliation Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Andy H. Szeto,
Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Katherine P. Morgan,
Roles Data curation, Investigation, Writing – original draft, Writing – review & editing
Affiliations Division of Practice Advancement and Experiential Education, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Pharmacy, UNC Hospitals and Clinics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Blaine Brower,
Roles Data curation, Investigation, Writing – original draft, Writing – review & editing
Affiliation Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Mary W. Dunn,
Roles Data curation, Investigation, Writing – original draft, Writing – review & editing
Affiliation Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Amir H. Khandani,
Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing
Affiliations Division of Molecular Imaging and Therapeutics, Department of Radiology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Paul A. Godley ,
Roles Investigation, Resources
¶†In memoriam.
Affiliations Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Tracy L. Rose,
Roles Investigation, Resources, Writing – original draft, Writing – review & editing
Affiliations Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Ethan M. Basch,
Roles Investigation, Resources, Writing – original draft, Writing – review & editing
Affiliations Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Matthew I. Milowsky,
Roles Formal analysis, Investigation, Supervision, Writing – original draft, Writing – review & editing
Affiliations Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Young E. Whang ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: daniel.crona@unc.edu (DJC); ywhang@med.unc.edu (YEW)
Affiliations Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯ -
Daniel J. Crona
Roles Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: daniel.crona@unc.edu (DJC); ywhang@med.unc.edu (YEW)
Affiliations Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, Department of Pharmacy, UNC Hospitals and Clinics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
- Stephanie I. Kim,
- Andy H. Szeto,
- Katherine P. Morgan,
- Blaine Brower,
- Mary W. Dunn,
- Amir H. Khandani,
- Paul A. Godley,
- Tracy L. Rose,
- Ethan M. Basch,
- Matthew I. Milowsky
- Published: June 21, 2021
- https://doi.org/10.1371/journal.pone.0253021